Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window
To help family physicians who care for patients with acute stroke or who are involved in planning service delivery or resource allocation to understand recent developments in acute stroke care. A MEDLINE search indicated that most data were derived from well designed, randomized, double-blind, place...
Gespeichert in:
| Veröffentlicht in: | Canadian family physician 2001-09, Vol.47 (9), p.1787-1793 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1793 |
|---|---|
| container_issue | 9 |
| container_start_page | 1787 |
| container_title | Canadian family physician |
| container_volume | 47 |
| creator | Herd, A M |
| description | To help family physicians who care for patients with acute stroke or who are involved in planning service delivery or resource allocation to understand recent developments in acute stroke care.
A MEDLINE search indicated that most data were derived from well designed, randomized, double-blind, placebo-controlled trials, including all the largest international studies and large systematic reviews.
Treatment of acute stroke with tissue plasminogen activator seems beneficial for certain patients with certain kinds of stroke. Because thrombolytic therapy is not without risk and requires substantial resources, it should be administered only by physicians trained in its use and in centres with the necessary experience and resources. Because time is important, an organized and efficient system of stroke care with collaboration between hospital and prehospital care providers and help from ordinary citizens is essential.
Management of acute stroke is an emerging discipline; many potential therapies are still experimental. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2018568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71189420</sourcerecordid><originalsourceid>FETCH-LOGICAL-h320t-180c2ded8eb10f28279aea1b3d604a8fffa48f3e7927d18262ff18fb9b3b37be3</originalsourceid><addsrcrecordid>eNpdkE1LxDAQhoso7rr6FyR48FbJR9ukHgRZ_AJBDyvsLaTtZJu1bTRpLfvvjbh-nmZgHt6ZZ3aiKeEkjVOait1oijEWMUvxchIdeL_GmGYJI_vRhJCUY4aTabScD85B16NWdWoF7UdrNVLl0AMyvqyhNSXyvbPPcIYelesROUeL2tm2sM2mN6VHqqtQXwNicW0Hh0bTVXY8jPa0ajwcbesserq-Wsxv4_uHm7v55X1cM4r7mAhc0goqAQXBmgrKcwWKFKzKcKKE1lolQjPgOeUVETSjWhOhi7xgBeMFsFl08Zn7MhQtVGUQcKqRL860ym2kVUb-nXSmliv7JikmIs1ECDjdBjj7OoDvZRu8oWlUB3bwkhMi8oTiAJ78A9dBtwtyISulhGcsC9Dx73O-7_j6-M-62qzq0TiQvlVNE3Aqx3FMuMwl4YKzd1BVjDY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205217636</pqid></control><display><type>article</type><title>Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Herd, A M</creator><creatorcontrib>Herd, A M</creatorcontrib><description>To help family physicians who care for patients with acute stroke or who are involved in planning service delivery or resource allocation to understand recent developments in acute stroke care.
A MEDLINE search indicated that most data were derived from well designed, randomized, double-blind, placebo-controlled trials, including all the largest international studies and large systematic reviews.
Treatment of acute stroke with tissue plasminogen activator seems beneficial for certain patients with certain kinds of stroke. Because thrombolytic therapy is not without risk and requires substantial resources, it should be administered only by physicians trained in its use and in centres with the necessary experience and resources. Because time is important, an organized and efficient system of stroke care with collaboration between hospital and prehospital care providers and help from ordinary citizens is essential.
Management of acute stroke is an emerging discipline; many potential therapies are still experimental.</description><identifier>ISSN: 0008-350X</identifier><identifier>EISSN: 1715-5258</identifier><identifier>PMID: 11570304</identifier><language>eng</language><publisher>Canada: The College of Family Physicians of Canada</publisher><subject>Adult ; Aged ; Brain Ischemia - drug therapy ; Delivery of Health Care ; Drug Administration Schedule ; Family medicine ; Family Practice ; Female ; Fibrinolytic Agents - administration & dosage ; Fibrinolytic Agents - pharmacology ; Humans ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Stroke ; Stroke - drug therapy ; Time Factors ; Treatment</subject><ispartof>Canadian family physician, 2001-09, Vol.47 (9), p.1787-1793</ispartof><rights>Copyright College of Family Physicians of Canada Sep 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2018568/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2018568/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11570304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herd, A M</creatorcontrib><title>Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window</title><title>Canadian family physician</title><addtitle>Can Fam Physician</addtitle><description>To help family physicians who care for patients with acute stroke or who are involved in planning service delivery or resource allocation to understand recent developments in acute stroke care.
A MEDLINE search indicated that most data were derived from well designed, randomized, double-blind, placebo-controlled trials, including all the largest international studies and large systematic reviews.
Treatment of acute stroke with tissue plasminogen activator seems beneficial for certain patients with certain kinds of stroke. Because thrombolytic therapy is not without risk and requires substantial resources, it should be administered only by physicians trained in its use and in centres with the necessary experience and resources. Because time is important, an organized and efficient system of stroke care with collaboration between hospital and prehospital care providers and help from ordinary citizens is essential.
Management of acute stroke is an emerging discipline; many potential therapies are still experimental.</description><subject>Adult</subject><subject>Aged</subject><subject>Brain Ischemia - drug therapy</subject><subject>Delivery of Health Care</subject><subject>Drug Administration Schedule</subject><subject>Family medicine</subject><subject>Family Practice</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration & dosage</subject><subject>Fibrinolytic Agents - pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Stroke</subject><subject>Stroke - drug therapy</subject><subject>Time Factors</subject><subject>Treatment</subject><issn>0008-350X</issn><issn>1715-5258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE1LxDAQhoso7rr6FyR48FbJR9ukHgRZ_AJBDyvsLaTtZJu1bTRpLfvvjbh-nmZgHt6ZZ3aiKeEkjVOait1oijEWMUvxchIdeL_GmGYJI_vRhJCUY4aTabScD85B16NWdWoF7UdrNVLl0AMyvqyhNSXyvbPPcIYelesROUeL2tm2sM2mN6VHqqtQXwNicW0Hh0bTVXY8jPa0ajwcbesserq-Wsxv4_uHm7v55X1cM4r7mAhc0goqAQXBmgrKcwWKFKzKcKKE1lolQjPgOeUVETSjWhOhi7xgBeMFsFl08Zn7MhQtVGUQcKqRL860ym2kVUb-nXSmliv7JikmIs1ECDjdBjj7OoDvZRu8oWlUB3bwkhMi8oTiAJ78A9dBtwtyISulhGcsC9Dx73O-7_j6-M-62qzq0TiQvlVNE3Aqx3FMuMwl4YKzd1BVjDY</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Herd, A M</creator><general>The College of Family Physicians of Canada</general><general>College of Family Physicians of Canada</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010901</creationdate><title>Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window</title><author>Herd, A M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h320t-180c2ded8eb10f28279aea1b3d604a8fffa48f3e7927d18262ff18fb9b3b37be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Brain Ischemia - drug therapy</topic><topic>Delivery of Health Care</topic><topic>Drug Administration Schedule</topic><topic>Family medicine</topic><topic>Family Practice</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration & dosage</topic><topic>Fibrinolytic Agents - pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Stroke</topic><topic>Stroke - drug therapy</topic><topic>Time Factors</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herd, A M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herd, A M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window</atitle><jtitle>Canadian family physician</jtitle><addtitle>Can Fam Physician</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>47</volume><issue>9</issue><spage>1787</spage><epage>1793</epage><pages>1787-1793</pages><issn>0008-350X</issn><eissn>1715-5258</eissn><abstract>To help family physicians who care for patients with acute stroke or who are involved in planning service delivery or resource allocation to understand recent developments in acute stroke care.
A MEDLINE search indicated that most data were derived from well designed, randomized, double-blind, placebo-controlled trials, including all the largest international studies and large systematic reviews.
Treatment of acute stroke with tissue plasminogen activator seems beneficial for certain patients with certain kinds of stroke. Because thrombolytic therapy is not without risk and requires substantial resources, it should be administered only by physicians trained in its use and in centres with the necessary experience and resources. Because time is important, an organized and efficient system of stroke care with collaboration between hospital and prehospital care providers and help from ordinary citizens is essential.
Management of acute stroke is an emerging discipline; many potential therapies are still experimental.</abstract><cop>Canada</cop><pub>The College of Family Physicians of Canada</pub><pmid>11570304</pmid><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-350X |
| ispartof | Canadian family physician, 2001-09, Vol.47 (9), p.1787-1793 |
| issn | 0008-350X 1715-5258 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2018568 |
| source | MEDLINE; Free E-Journal (出版社公開部分のみ）; PubMed Central; Alma/SFX Local Collection |
| subjects | Adult Aged Brain Ischemia - drug therapy Delivery of Health Care Drug Administration Schedule Family medicine Family Practice Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - pharmacology Humans Male Middle Aged Randomized Controlled Trials as Topic Stroke Stroke - drug therapy Time Factors Treatment |
| title | Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A52%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20management%20of%20acute%20ischemic%20stroke.%20Part%201:%20Thrombolytics%20and%20the%203-hour%20window&rft.jtitle=Canadian%20family%20physician&rft.au=Herd,%20A%20M&rft.date=2001-09-01&rft.volume=47&rft.issue=9&rft.spage=1787&rft.epage=1793&rft.pages=1787-1793&rft.issn=0008-350X&rft.eissn=1715-5258&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71189420%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205217636&rft_id=info:pmid/11570304&rfr_iscdi=true |